Risk Factors, Pathogenesis, Diagnosis, and Treatment Options for COVID-Associated Osteonecrosis: A Systematic Review
The Journal of Arthroplasty · 2025
DOI: 10.1016/j.arth.2025.06.015 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Journal of Arthroplasty, 2025. Verfasst von Sean B Sequeira und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Medstar Union Memorial Hospital, Baltimore, Maryland. Hauptthemen laut MEDLINE: COVID-19, Osteonecrosis. Die Arbeit nennt 22 Literaturangaben. Gefördert von: NIAMS NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Osteonecrosis associated with COVID-19 is a relatively rare clinical entity, but with a high incidence during the pandemic. There is a paucity of data regarding the characterization of this group of osteonecrosis patients. The purpose of this investigation was to systematically review the literature to identify: (1) clinical presentation/epidemiology, (2) pathophysiology, (3) diagnostic modalities, and (4) treatment guidelines/algorithms of COVID-19 osteonecrosis. METHODS: Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we conducted a systematic review across three databases, resulting in a total of 10 articles. Articles met the inclusion criteria if they provided data regarding: (1) clinical presentation/epidemiology, (2) pathophysiology, (3) diagnostic modalities, and/or (4) treatment guidelines/algorithms of COVID-19 osteonecrosis. RESULTS: There was considerable variability in duration between COVID-19 infection and osteonecrosis symptoms. The clinical presentation of COVID-associated osteonecrosis is similar to standard symptoms, including joint pain and pain with weight-bearing. Corticosteroids tended to be the most identifiable associated risk factor for COVID-associated osteonecrosis. Diagnosis included radiographs and magnetic resonance imaging for definitive diagnosis. Treatment varied depending on the rapidity of osteonecrosis progression, ranging from bisphosphonates and analgesics to joint-preserving procedures and total joint arthroplasty. CONCLUSIONS: Although COVID-associated osteonecrosis is a rare clinical condition, it is one that orthopaedic surgeons should be aware of and meticulously screen for in their patients. For patients inoculated with the COVID-19 virus, it is important for surgeons to use information regarding clinical presentation, pathophysiology, diagnosis, and treatment of COVID-associated osteonecrosis to screen and manage patients appropriately.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Medstar Union Memorial Hospital, Baltimore, Maryland.
- Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
- Department of Orthopaedic Surgery, Stanford University, Redwood City, California.
- Rubin Institute for Advanced Orthopaedics Sinai Hospital of Baltimore, Baltimore, Maryland.
Förderung
- NIAMS NIH HHS
Zitieren
APA
Sequeira, S. B., Jones, L. P., Goodman, S. B., & Mont, M. A. (2025). Risk Factors, Pathogenesis, Diagnosis, and Treatment Options for COVID-Associated Osteonecrosis: A Systematic Review. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2025.06.015
Vancouver
Sequeira SB, Jones LP, Goodman SB, Mont MA. Risk Factors, Pathogenesis, Diagnosis, and Treatment Options for COVID-Associated Osteonecrosis: A Systematic Review. The Journal of Arthroplasty. 2025. doi:10.1016/j.arth.2025.06.015
BibTeX
@article{Sequeira2025,
author = {Sequeira, Sean B and Jones, Lynne P and Goodman, Stuart B and Mont, Michael A},
title = {Risk Factors, Pathogenesis, Diagnosis, and Treatment Options for COVID-Associated Osteonecrosis: A Systematic Review},
journal = {The Journal of Arthroplasty},
year = {2025},
doi = {10.1016/j.arth.2025.06.015}
}
EUVIMED